FY2025 EPS Estimate for DENTSPLY SIRONA Boosted by Analyst

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Analysts at Barrington Research boosted their FY2025 earnings per share (EPS) estimates for DENTSPLY SIRONA in a report issued on Monday, May 12th. Barrington Research analyst M. Petusky now anticipates that the medical instruments supplier will post earnings of $1.90 per share for the year, up from their previous forecast of $1.86. Barrington Research has a "Outperform" rating and a $21.00 price target on the stock. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Barrington Research also issued estimates for DENTSPLY SIRONA's FY2026 earnings at $2.10 EPS.

Other analysts have also issued research reports about the company. Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a report on Tuesday, April 15th. StockNews.com upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Wells Fargo & Company cut their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Finally, Robert W. Baird cut their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Eleven investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has an average rating of "Hold" and an average price target of $20.36.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock traded down $0.12 during trading on Wednesday, hitting $16.59. The stock had a trading volume of 432,536 shares, compared to its average volume of 2,999,515. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market cap of $3.31 billion, a P/E ratio of -8.01, a PEG ratio of 1.80 and a beta of 0.92. The business has a fifty day moving average of $14.41 and a two-hundred day moving average of $17.30. DENTSPLY SIRONA has a fifty-two week low of $12.16 and a fifty-two week high of $28.44.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The firm had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's revenue was down 7.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.42 EPS.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 3.86%. DENTSPLY SIRONA's dividend payout ratio is -14.10%.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier acquired 15,142 shares of DENTSPLY SIRONA stock in a transaction on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.50% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Colonial Trust Co SC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth $26,000. Riverview Trust Co bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth $26,000. MassMutual Private Wealth & Trust FSB boosted its position in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. boosted its position in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 564 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in shares of DENTSPLY SIRONA in the 1st quarter worth $25,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.